Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBlood in stool is not a listed common side effect of semaglutide, but the question deserves a straight answer: gastrointestinal symptoms are the most frequently reported effects of semaglutide, and in some cases those symptoms can become severe enough to warrant urgent medical attention. If you notice bright red blood, dark tarry stools, or any rectal bleeding while taking semaglutide, contact a clinician the same day — do not wait for your next scheduled review. These are prescription-only medicines, and suitability, dose and any concerning symptoms should be discussed with the prescriber who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works on GLP-1 receptors in the gut as well as the brain. One direct result is slower gastric emptying, food moves through the stomach more gradually, which reduces appetite but also alters the rhythm of the whole digestive tract. For many people this produces nausea, loose stools or constipation, especially in the weeks after a dose increase. The NHS medicines page for semaglutide lists these GI effects clearly as the most common reactions.
None of that directly damages the bowel wall in the way that, say, certain anti-inflammatory drugs can. Semaglutide is not a cause of gastrointestinal bleeding in the same mechanistic sense. That distinction matters, because it shapes how seriously you take blood in your stool, and the honest answer is: seriously, regardless of mechanism.
Straining from constipation can irritate haemorrhoids or small anal fissures and produce a small amount of bright red blood on tissue. That is worth mentioning to your prescriber but is unlikely to be dangerous. A larger volume of blood, dark or tarry stools, or blood mixed through the stool is a different matter entirely, and one that needs same-day clinical assessment.
There are three conditions associated with GLP-1 receptor agonists that can cause abdominal pain and, in some cases, affect stool appearance: acute pancreatitis, gallbladder disease, and (more rarely) bowel obstruction. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines; the symptom to watch for is severe, persistent stomach pain that radiates to the back, with or without vomiting. That kind of pain needs emergency care.
Pancreatitis itself can indirectly affect digestion in ways that change stool colour and consistency. Gallbladder problems (gallstones form more readily during significant weight loss) can produce pale or greasy stools alongside upper-right abdominal pain. Neither of these is blood in stool in the conventional sense, but both are reasons to be seen urgently rather than waiting it out. Our Wegovy treatment overview includes a summary of the safety monitoring that runs alongside any GLP-1 prescription.
If you are on semaglutide and develop severe abdominal symptoms of any kind, stop the injection and seek urgent help. Do not restart until a clinician has assessed you.
A lot of people who search this question have read something online suggesting that GLP-1 medicines cause internal bleeding. It is worth setting that down gently: the current evidence does not support the idea that semaglutide routinely causes gastrointestinal bleeding in otherwise healthy adults. What it does cause, reliably, is GI disruption, and in some people, that disruption is significant enough that pre-existing conditions (haemorrhoids, irritable bowel, inflammatory bowel disease) are aggravated. The blood someone sees may genuinely be connected to treatment, not because the drug bleeds the gut, but because altered motility and straining can tip a susceptible person into a flare.
This is exactly why a thorough medical history matters before a prescription is written. A GPhC-registered Independent Prescriber at a regulated pharmacy will ask about bowel history, existing conditions and any medications that could affect bleeding risk. Semaglutide is a prescription-only medicine for a reason, the clinical assessment before treatment is not a formality.
You may also find it useful to read about loose stool as a side effect of semaglutide, which is far more common and usually manageable. If you want a fuller picture of what to watch for during treatment, our page on Wegovy and blood in stool covers the topic in more depth, including when symptoms need urgent attention. A separate but related question (whether semaglutide can cause changes to urinary symptoms) is covered on our page about blood in urine and Wegovy.
The practical decision tree is simple. Bright red blood, small amount, clearly linked to straining or a known haemorrhoid: mention it at your next prescriber contact and keep an eye on it. Any doubt about the source, a larger amount, dark or tarry stools, blood mixed through the stool, or abdominal pain alongside the bleeding: contact a clinician the same day. If pain is severe or bleeding is significant, call 111 or go to A&E.
Report any suspected side effects using the MHRA's Yellow Card scheme, this applies to all prescription medicines, and the data genuinely shapes future safety guidance. You can report as a patient, not just as a healthcare professional. It is also worth knowing that storing your medication correctly affects how well it works, so if you are unsure whether your pens are still safe to use, our guide to Wegovy expiration dates explains what to check and when to discard a pen.
If you have concerns about your current treatment or are considering starting semaglutide and want to understand the risk profile first, our prescribers review every consultation individually. You can check your eligibility and ask questions before any decision is made.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.